Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LifeVantage joins with Cornerstone R&D

This article was originally published in The Tan Sheet

Executive Summary

San Diego, Calif.-based nutraceutical firm LifeVantage Corporation teams with Utah-based Cornerstone Research and Development firm to cut product manufacturing costs significantly, LifeVantage says in an Aug. 21 release. The merger will cut in half the costs for manufacturing LifeVantage's anti-oxidant therapy Protandim, the firm's President and CEO David Brown says. LifeVantage also points out Cornerstone's good manufacturing practice certification will boost business opportunities for the firm

You may also be interested in...



Quick Listen: Scrip’s Five Must-Know Things

Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip

Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

CBD Sheet Mask Brand Fails To Sway NAD: We Only Claimed It ‘May’ Have Benefits

The National Advertising Division has notified the US Federal Trade Commission of claims seen at Bloomingdales.com for one of Mask, LLC’s CBD-infused sheet masks, including the product’s name, which implies unsupported acne treatment benefits, according to the NAD.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel